| # | Title | Journal | Year | Citations |
|---|
|
| 1 | Design and validation of a histological scoring system for nonalcoholic fatty liver disease | Hepatology | 2005 | 8,842 |
| 2 | Global epidemiology of nonalcoholic fatty liver disease—Meta‐analytic assessment of prevalence, incidence, and outcomes | Hepatology | 2016 | 7,900 |
| 3 | Management of hepatocellular carcinoma: An update | Hepatology | 2011 | 7,214 |
| 4 | Management of hepatocellular carcinoma | Hepatology | 2005 | 5,462 |
| 5 | The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases | Hepatology | 2018 | 5,091 |
| 6 | A model to predict survival in patients with end-stage liver disease | Hepatology | 2001 | 4,195 |
| 7 | An algorithm for the grading of activity in chronic hepatitis C | Hepatology | 1996 | 3,653 |
| 8 | A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C | Hepatology | 2003 | 3,549 |
| 9 | Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfection | Hepatology | 2006 | 3,545 |
| 10 | Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis | Hepatology | 1981 | 3,360 |
| 11 | Diagnosis, Staging, and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases | Hepatology | 2018 | 3,356 |
| 12 | Prevalence of hepatic steatosis in an urban population in the United States: Impact of ethnicity | Hepatology | 2004 | 3,293 |
| 13 | AASLD guidelines for the treatment of hepatocellular carcinoma | Hepatology | 2018 | 3,124 |
| 14 | The diagnosis and management of non-alcoholic fatty liver disease: Practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association | Hepatology | 2012 | 3,004 |
| 15 | Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance | Hepatology | 2018 | 2,876 |
| 16 | Systematic review of randomized trials for unresectable hepatocellular carcinoma: Chemoembolization improves survival | Hepatology | 2003 | 2,682 |
| 17 | Diagnosis, management, and treatment of hepatitis C: An update | Hepatology | 2009 | 2,631 |
| 18 | The NAFLD fibrosis score: A noninvasive system that identifies liver fibrosis in patients with NAFLD | Hepatology | 2007 | 2,552 |
| 19 | Chronic hepatitis B: Update 2009 | Hepatology | 2009 | 2,525 |
| 20 | A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts | Hepatology | 2000 | 2,521 |
| 21 | Classification of chronic hepatitis: Diagnosis, grading and staging | Hepatology | 1994 | 2,489 |
| 22 | Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma | Hepatology | 2002 | 2,350 |
| 23 | Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome | Hepatology | 2003 | 2,302 |
| 24 | Intraobserver and Interobserver Variations in Liver Biopsy Interpretation in Patients with Chronic Hepatitis C | Hepatology | 1994 | 2,220 |
| 25 | Nonalcoholic Fatty Liver Disease: From Steatosis to Cirrhosis | Hepatology | 2006 | 2,139 |
| 26 | Global epidemiology of hepatitis C virus infection: New estimates of age-specific antibody to HCV seroprevalence | Hepatology | 2013 | 2,139 |
| 27 | Long-term follow-up of patients with NAFLD and elevated liver enzymes | Hepatology | 2006 | 2,069 |
| 28 | Liver transplantation for hepatocellular carcinoma: Expansion of the tumor size limits does not adversely impact survival | Hepatology | 2001 | 1,978 |
| 29 | Evolution of inflammation in nonalcoholic fatty liver disease: The multiple parallel hits hypothesis | Hepatology | 2010 | 1,925 |
| 30 | Intention-to-treat analysis of surgical treatment for early hepatocellular carcinoma: Resection versus transplantation | Hepatology | 1999 | 1,884 |
| 31 | Sampling variability of liver fibrosis in chronic hepatitis C | Hepatology | 2003 | 1,810 |
| 32 | Nonalcoholic steatohepatitis: Summary of an AASLD Single Topic Conference | Hepatology | 2003 | 1,805 |
| 33 | Hepatic encephalopathy-Definition, nomenclature, diagnosis, and quantification: Final report of the Working Party at the 11th World Congresses of Gastroenterology, Vienna, 1998 | Hepatology | 2002 | 1,775 |
| 34 | Fibrosis stage is the strongest predictor for disease‐specific mortality in NAFLD after up to 33 years of follow‐up | Hepatology | 2015 | 1,761 |
| 35 | Acetaminophen-induced acute liver failure: Results of a United States multicenter, prospective study | Hepatology | 2005 | 1,710 |
| 36 | FIB-4: An inexpensive and accurate marker of fibrosis in HCV infection. comparison with liver biopsy and fibrotest | Hepatology | 2007 | 1,708 |
| 37 | AASLD guidelines for treatment of chronic hepatitis B | Hepatology | 2016 | 1,707 |
| 38 | Prevention and management of gastroesophageal varices and variceal hemorrhage in cirrhosis | Hepatology | 2007 | 1,696 |
| 39 | Obesity and nonalcoholic fatty liver disease: Biochemical, metabolic, and clinical implications | Hepatology | 2010 | 1,653 |
| 40 | Portal hypertensive bleeding in cirrhosis: Risk stratification, diagnosis, and management: 2016 practice guidance by the American Association for the study of liver diseases | Hepatology | 2017 | 1,624 |
| 41 | Modeling the epidemic of nonalcoholic fatty liver disease demonstrates an exponential increase in burden of disease | Hepatology | 2018 | 1,622 |
| 42 | Simplified criteria for the diagnosis of autoimmune hepatitis | Hepatology | 2008 | 1,603 |
| 43 | Hepatic encephalopathy in chronic liver disease: 2014 Practice Guideline by the American Association for the Study Of Liver Diseases and the European Association for the Study of the Liver | Hepatology | 2014 | 1,569 |
| 44 | Peripheral arterial vasodilation hypothesis: A proposal for the initiation of renal sodium and water retention in cirrhosis | Hepatology | 1988 | 1,529 |
| 45 | Diagnosis, management, and treatment of hepatitis C | Hepatology | 2004 | 1,514 |
| 46 | Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis | Hepatology | 1999 | 1,460 |
| 47 | Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis | Hepatology | 1996 | 1,427 |
| 48 | The model for end-stage liver disease (MELD) | Hepatology | 2007 | 1,407 |
| 49 | Characterization of gut microbiomes in nonalcoholic steatohepatitis (NASH) patients: A connection between endogenous alcohol and NASH | Hepatology | 2013 | 1,394 |
| 50 | Activation of the p62‐Keap1‐NRF2 pathway protects against ferroptosis in hepatocellular carcinoma cells | Hepatology | 2016 | 1,394 |
